Three male patients (aged 41, 71 and 65 years) with untreated severe hypothyroidism of long duration were in a state of coma. This had been preceded by respiratory symptoms accompanied by hypoxemia and hypercapnea.
Three male patients (aged 41, 71 and 65 years) with untreated severe hypothyroidism of long duration were in a state of coma. This had been preceded by respiratory symptoms accompanied by hypoxemia and hypercapnea. There were also various chest radiographic findings.
All the patients were treated with mechanical ventilatory assistance, circulatory support and i. v. administration of high doses of l-triiodo-thyronine (T3) during the early period of treatment.
None of the patients showed any serious cardiac ill-effects immediately or a few days following the intravenous administration of T3. In spite of the stabilisation of vital signs and improvement in arterial oxygenation, the patients remained in a comatous or semicomatous state for the first few days.
During the second week, the condition of their lungs deteriorated and prolonged respiratory failure ensued with fever, rales, excessive bronchial secretion, homogenous densities in the chest radiograms and persistent hypoxemia even though mechanical ventilatory treatment was continued. The implications of this delayed respiratory failure during the treatment of myxedema coma are discussed.
Myxedema coma is a rare and life-threatening complication of long-standing, severe hypothyroidism.
Its occurrence at present is very infrequent probably because of early detection of clinical and subclinical hypothyroidism by wide application of measurement of serum thyroid and thyrotropic hormones by radioimmunoassays (RIA). Rapid thyroid hormone replacement, such as either l-thyroxine (T4) or l-3, 3', 5-tri-iodo-thyronine (T3), is recommended since the depleted extra-thyroidal pool of thyroid hormone must be refilled promptly to save the life of victims (Cats and Russel, 1961; Holvey et al., 1964) . In addition, circulatory support, adrenocorticosteroids, mechanical venti latory assistance and careful monitoring of cardio-pulmonary function presumably improve the prognosis of this complication.
In the present report, the clinical course of each of three patients with myxedema coma is described.
At the time of their admission to hospital, they were in a state of coma, accompanied by acute respiratory failure and various radiologically detected chest abnormalities.
All the patients were given mechanical ventilatory assistance, careful monitoring and management of circulation, and high doses of parenteral thyroid hormone replacement.
In spite of stabilisa- Case 1. 41-year-old man, a recluse since his late teens, was brought to the hospital by his family after he lost consciousness. Following development of upper respiratory illness one week prior to admission, his mentation became progressively obtunded into deep coma. The man was of short statue and had disproportionately short extremities. His respiration was shallow and infrequent and the blood pressure 78mmHg by palpation. Dry, scaly skin, puffy face, distant heart sound, and distended abdomen were noticed. The peripheral blood showed mild normocytic anemia. The BUN was 17.6mg/dl, creatinine, 2.0mg/dl, and sodium, 139mEq/L. The partial pressures of the arterial oxygen and carbon dioxide (Pa02, PaCO2) were 39.9, 46.2mmHg, respectively. The chest roentgenogram showed an overt cardiomegaly, atelectasis of the left lung and pleural effusion on the same side. The patient was initially given mechanical ventilatory treatment, intravenous infusion of vasopressor, and hormonal replacement with desiccated thyroid, 20mg per day using a nasogastric tube, along with hydrocortisone, for a presumptive diagnosis of myxedema coma. He remained semicomatous for the first 3 days, with his blood pressure kept at a systolic level of 100 to 120mmHg by means of a vasopressor. The daily urine output exceeded 1,500ml/day and was above the total intake. The central venous pressure was less than 10cm H2O. PaO2 increased gradually to 79mmHg by maintaining a higher fraction of inspired oxygen (FIO2 
Discussion
There is no apparent established definition of myxedema coma in the literature. The term has been used in reference to impaired consciousness observed at the late stage of long-standing, untreated hypothyroidism. Although the cause of coma has not been fully determined in the case of thyroid hormone deficiency per se, or thyroprival cerebral, cardiac and/or pulmonary dysfunction, it is quite distinct from the cause of coma in hypothyroid patients occurring apparently as a result of stroke, shock or metabolic derangement in otherwise stable, untreated hypothyroidism. This has been shown by the data obtained from the three patients described above.
Coma and respiratory failure were common to all three patients. Respiratory failure with CO2 narcosis is considered to be a cause of myxedema coma (Nordqvist et al., 1960) and several such cases have been reported (Massumi and Winnicker, 1964; Buchanan et al., 1967; Buckle and Garfield, 1969; Boyd et al., 1969; Domms and Vassalo, 1973; Nicholis and Hunt, 1976 ) but this does not seem related to our patients since the CO2 retention before therapy was only modest. Hypoxemia per se does not seem to be the cause of coma, either, since consciousness disturbance persisted following normalization of PaO2 by mechanical ventilatory treatment for a few days. Respiratory dysfunction is known to accompany myxedema as a result of the reduced sensitivity of the respiratory center to hypoxemia and hypercapnea (Massumi and Winnicker, 1964; Domms and Vassalo, 1973; Zwillich et al., 1975) , impaired bellow function of the respiratory muscles (Wilson and Bedell, 1960) , and the obstruction of the upper airway (Yamamoto et al., 1977; Orr et al., 1981) . Most of these abnormalities can be eliminated through adequate ventilatory treatment unless complicated by intrinsic lung diseases. 
